カテゴリー： Market Monitor Global, 世界, 医療/バイオ

BCL-2（B 細胞リンパ腫 2）阻害剤の世界市場見通し2023年-2029年

◆英語タイトル：BCL-2 (B-cell lymphoma 2) Inhibitors Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5710）

◆商品コード：MMG23JU5710
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：63
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥474,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥616,850	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥711,750	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market 調査レポートは次の情報を含め、グローバルにおけるのBCL-2（B 細胞リンパ腫 2）阻害剤市場規模と予測を収録しています。・世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場：売上、2018年-2023年、2024年-2029年
・世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「併用療法」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

BCL-2（B 細胞リンパ腫 2）阻害剤のグローバル主要企業は、AbbVie Inc.、 F. Hoffmann-La Roche Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、BCL-2（B 細胞リンパ腫 2）阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場：タイプ別、2018年-2023年、2024年-2029年
世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場：タイプ別市場シェア、2022年
・併用療法、単剤療法

世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場：用途別、2018年-2023年、2024年-2029年
世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場：用途別市場シェア、2022年
・がん、自己免疫疾患、その他

世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場：地域・国別、2018年-2023年、2024年-2029年
世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるBCL-2（B 細胞リンパ腫 2）阻害剤のグローバル売上、2018年-2023年
・主要企業におけるBCL-2（B 細胞リンパ腫 2）阻害剤のグローバル売上シェア、2022年
・主要企業におけるBCL-2（B 細胞リンパ腫 2）阻害剤のグローバル販売量、2018年-2023年
・主要企業におけるBCL-2（B 細胞リンパ腫 2）阻害剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AbbVie Inc.、 F. Hoffmann-La Roche Ltd.

*************************************************************

・調査・分析レポートの概要
BCL-2（B 細胞リンパ腫 2）阻害剤市場の定義
市場セグメント
世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場規模
世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場規模：2022年 VS 2029年
世界のBCL-2（B 細胞リンパ腫 2）阻害剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのBCL-2（B 細胞リンパ腫 2）阻害剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のBCL-2（B 細胞リンパ腫 2）阻害剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：併用療法、単剤療法
BCL-2（B 細胞リンパ腫 2）阻害剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：がん、自己免疫疾患、その他
BCL-2（B 細胞リンパ腫 2）阻害剤の用途別グローバル売上・予測

・地域別市場分析
地域別BCL-2（B 細胞リンパ腫 2）阻害剤市場規模 2022年と2029年
地域別BCL-2（B 細胞リンパ腫 2）阻害剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AbbVie Inc.、 F. Hoffmann-La Roche Ltd.
...

Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.
This report aims to provide a comprehensive presentation of the global market for BCL-2 (B-cell lymphoma 2) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCL-2 (B-cell lymphoma 2) Inhibitors. This report contains market size and forecasts of BCL-2 (B-cell lymphoma 2) Inhibitors in global, including the following market information:
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global BCL-2 (B-cell lymphoma 2) Inhibitors market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Combination therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of BCL-2 (B-cell lymphoma 2) Inhibitors include AbbVie Inc. and F. Hoffmann-La Roche Ltd. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the BCL-2 (B-cell lymphoma 2) Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Segment Percentages, by Type, 2022 (%)
Combination therapy
Monotherapy
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Segment Percentages, by Application, 2022 (%)
Cancer
Auto-immune diseases
Other
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies BCL-2 (B-cell lymphoma 2) Inhibitors revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies BCL-2 (B-cell lymphoma 2) Inhibitors revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of BCL-2 (B-cell lymphoma 2) Inhibitors, market overview.
Chapter 2: Global BCL-2 (B-cell lymphoma 2) Inhibitors market size in revenue.
Chapter 3: Detailed analysis of BCL-2 (B-cell lymphoma 2) Inhibitors company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of BCL-2 (B-cell lymphoma 2) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 BCL-2 (B-cell lymphoma 2) Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Overall Market Size
2.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size: 2022 VS 2029
2.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top BCL-2 (B-cell lymphoma 2) Inhibitors Players in Global Market
3.2 Top Global BCL-2 (B-cell lymphoma 2) Inhibitors Companies Ranked by Revenue
3.3 Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 BCL-2 (B-cell lymphoma 2) Inhibitors Companies in Global Market, by Revenue in 2022
3.5 Global Companies BCL-2 (B-cell lymphoma 2) Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 BCL-2 (B-cell lymphoma 2) Inhibitors Players in Global Market
3.6.1 List of Global Tier 1 BCL-2 (B-cell lymphoma 2) Inhibitors Companies
3.6.2 List of Global Tier 2 and Tier 3 BCL-2 (B-cell lymphoma 2) Inhibitors Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Markets, 2022 & 2029
4.1.2 Combination therapy
4.1.3 Monotherapy
4.2 By Type – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue & Forecasts
4.2.1 By Type – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2018-2023
4.2.2 By Type – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2024-2029
4.2.3 By Type – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Auto-immune diseases
5.1.4 Other
5.2 By Application – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue & Forecasts
5.2.1 By Application – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2018-2023
5.2.2 By Application – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2024-2029
5.2.3 By Application – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2022 & 2029
6.2 By Region – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue & Forecasts
6.2.1 By Region – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2018-2023
6.2.2 By Region – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2024-2029
6.2.3 By Region – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2018-2029
6.3.2 US BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.3.3 Canada BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.3.4 Mexico BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2018-2029
6.4.2 Germany BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.4.3 France BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.4.4 U.K. BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.4.5 Italy BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.4.6 Russia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.4.7 Nordic Countries BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.4.8 Benelux BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2018-2029
6.5.2 China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.5.3 Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.5.4 South Korea BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.5.5 Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.5.6 India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2018-2029
6.6.2 Brazil BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.6.3 Argentina BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2018-2029
6.7.2 Turkey BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.7.3 Israel BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.7.4 Saudi Arabia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
6.7.5 UAE BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2018-2029
7 BCL-2 (B-cell lymphoma 2) Inhibitors Companies Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Company Summary
7.1.2 AbbVie Inc. Business Overview
7.1.3 AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Major Product Offerings
7.1.4 AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global Market (2018-2023)
7.1.5 AbbVie Inc. Key News & Latest Developments
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 F. Hoffmann-La Roche Ltd. Company Summary
7.2.2 F. Hoffmann-La Roche Ltd. Business Overview
7.2.3 F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global Market (2018-2023)
7.2.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. BCL-2 (B-cell lymphoma 2) Inhibitors Market Opportunities & Trends in Global Market
Table 2. BCL-2 (B-cell lymphoma 2) Inhibitors Market Drivers in Global Market
Table 3. BCL-2 (B-cell lymphoma 2) Inhibitors Market Restraints in Global Market
Table 4. Key Players of BCL-2 (B-cell lymphoma 2) Inhibitors in Global Market
Table 5. Top BCL-2 (B-cell lymphoma 2) Inhibitors Players in Global Market, Ranking by Revenue (2022)
Table 6. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Share by Companies, 2018-2023
Table 8. Global Companies BCL-2 (B-cell lymphoma 2) Inhibitors Product Type
Table 9. List of Global Tier 1 BCL-2 (B-cell lymphoma 2) Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 BCL-2 (B-cell lymphoma 2) Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2024-2029
Table 30. AbbVie Inc. Company Summary
Table 31. AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Product Offerings
Table 32. AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Inc. Key News & Latest Developments
Table 34. F. Hoffmann-La Roche Ltd. Company Summary
Table 35. F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Product Offerings
Table 36. F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 37. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
List of Figures
Figure 1. BCL-2 (B-cell lymphoma 2) Inhibitors Segment by Type in 2022
Figure 2. BCL-2 (B-cell lymphoma 2) Inhibitors Segment by Application in 2022
Figure 3. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in 2022
Figure 8. By Type - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
Figure 9. By Application - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
Figure 10. By Type - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
Figure 12. By Application - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
Figure 14. By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
Figure 15. By Country - North America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
Figure 16. US BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 17. Canada BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
Figure 20. Germany BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 21. France BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 23. Italy BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 24. Russia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
Figure 28. China BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 29. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 32. India BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
Figure 34. Brazil BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2018-2029
Figure 37. Turkey BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 38. Israel BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 40. UAE BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 41. AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ BCL-2（B 細胞リンパ腫 2）阻害剤の世界市場見通し2023年-2029年(BCL-2 (B-cell lymphoma 2) Inhibitors Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

BCL-2（B 細胞リンパ腫 2）阻害剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp